slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 78,991-79,020
Pages 3,679
Rows per page 30
Component
78,991-79,020 of 110,355
03
The slide includes a footnote regarding F/X adjusted figures.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
04
The bar chart shows growth over five quarters, while the pie chart shows the composition of net sales.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
12
The chart highlights a 4% year-over-year increase in FCF, with a footnote clarifying that operating cash flow increased 36% Y/Y.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
19
TTM stands for Trailing Twelve Months. The table reconciles Operating Cash Flow to a specific adjusted Free Cash Flow metric.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
03
The slide uses a three-column layout to summarize key strategic pillars: clinical assets, development timeline, and platform pedigree.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to show the development stage of multiple drug candidates.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
06
The slide uses a timeline-based framework to categorize R&D milestones and market opportunities.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
09
Includes clinical trial timeline diagram and outcome tables.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Market Size1 hit
10
The table uses blue highlighting to emphasize the higher severity metrics in the EBO Ph 2 group.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
11
LSM = Least squares mean. PRO = Patient-Reported Outcome. The slide highlights alignment with FDA guidance for primary endpoints in NTM trials.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
12
The chart highlights a statistically significant improvement (p=0.036) at month 6.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
13
The chart shows a longitudinal comparison of two treatment groups over 6 months. The p-value of 0.043 indicates nominal statistical significance for the difference in mean change from baseline.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
20
The chart shows Log10 CFU counts in lungs for various treatment groups compared to untreated control.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
Includes a disease progression timeline diagram on the right.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
24
The slide uses a hub-and-spoke diagram to show the global burden relative to specific regions.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
25
The slide uses a dot map to visualize geographic distribution of infections.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
26
Includes chemical structure of the benzoxaborole molecule.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
27
The chart demonstrates superior efficacy of the lead compound over existing treatments (Benznidazole and E1224) in a model that mirrors human clinical outcomes.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
05
The slide uses a three-row layout to highlight financial, clinical, and regulatory achievements.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · AttentionLoop · Aha Moment1 hit
06
The slide uses stacked bar charts to show composition and waterfall-style segments for growth analysis.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Aha Moment1 hit
07
The slide uses a combination of a bar chart and a map to visualize market growth and reach, emphasizing the strategic importance of emerging markets.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Aha Moment1 hit
08
The slide highlights both existing drug expansion and new drug development milestones.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Aha Moment1 hit
15
The chart shows revenue breakdown by product over 8 quarters. The right side provides qualitative commentary on specific product performance and regulatory updates.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Slide 19 of a presentation; includes revenue charts for CVRM and R&I segments and a list of key Q4 2024 dynamics.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · VisualizationLoop · Golden Circle1 hit
23
The chart shows a stacked bar breakdown of revenue by product (Ultomiris, Soliris, Strensiq, Koselugo PS, Koselugo CR, Other) across 8 quarters.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · VisualizationLoop · Golden Circle1 hit
27
The slide uses a three-column layout with icons to represent strategic pillars.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
29
The slide uses a three-column layout with icons to represent financial and operational goals.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
10
Slide 10 from a Tesla investor deck.Tesla | Results Presentation Deck | 36 slides · Tesla
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
14
The chart uses a red bar to emphasize the Q4 2024 data point.Tesla | Results Presentation Deck | 36 slides · Tesla
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
34
Includes TTM data starting from 1Q-2022.Tesla | Results Presentation Deck | 36 slides · Tesla
Conference presentation Investor relations Beat · Action1 hit